Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06677112 · ClinicalTrials.gov registry record · NA
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
A NA study of Endometrial Cancer, sponsored by Rachel Miller.
- Recruiting
- Registry status
- NA
- Development phase
- 625
- Enrollment target
- 1
- Study location
NCT06677112: Recruiting NA study of Endometrial Cancer, sponsored by Rachel Miller.
NCT06677112 is a NA study of Endometrial Cancer that is actively recruiting participants, run by Rachel Miller. The registered enrollment target is 625 participants, above the 521-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06677112, a NA study of Endometrial Cancer, is actively recruiting participants, sponsored by Rachel Miller.
- RECRUITING
- Registry status
- NA
- Development phase
- 625 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging. This study will gather information to help determine the best way to evaluate lymph nodes during surgery for endometrial cancer.
Primary Outcome
Participants with no measurable disease from study entry until disease recurrence, death, or date of the last contact
Conditions Studied
Interventions
- PROCEDURE Selective surgical staging
- PROCEDURE REFLEX
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 625 participants |
| Start Date | 2025-03-17 |
| Est. Completion | 2030-01 |
| Phase | NA |
What NCT06677112 shows while recruiting
NCT06677112 is an interventional study that assigns participants to a tested intervention. The registered 625 participants enrollment target is mid-sized for trials with a published cap, above the 521-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (20% higher).
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 2 interventions - of which Selective surgical staging is the first listed.
NCT06677112 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06677112 about?
NCT06677112 is a clinical study titled "MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer". This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging. This study will gather information to help determine the best way to evaluate lymph nodes during surgery for endometrial cancer.
What is the current status of trial NCT06677112?
This trial is currently recruiting. It is a NA study. The enrollment target is 625 participants. The study started on 2025-03-17. Estimated completion is 2030-01.
What conditions does trial NCT06677112 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT06677112?
The interventions under investigation include: Selective surgical staging (PROCEDURE), REFLEX (PROCEDURE).
Who is sponsoring clinical trial NCT06677112?
This trial is sponsored by Rachel Miller, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06677112 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06677112's enrollment target sits among peer trials
625 24th of 181 higher than 157 of 181 other Endometrial Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
RECRUITING · NA
-
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
- NCT06040827 · 626 participants
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
- NCT06406049 · 624 participants · NA
Finishing HIV Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI